Claire Guyomard

2.1k total citations · 1 hit paper
20 papers, 1.7k citations indexed

About

Claire Guyomard is a scholar working on Hepatology, Surgery and Pharmacology. According to data from OpenAlex, Claire Guyomard has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 8 papers in Surgery and 6 papers in Pharmacology. Recurrent topics in Claire Guyomard's work include Liver physiology and pathology (11 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Claire Guyomard is often cited by papers focused on Liver physiology and pathology (11 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Claire Guyomard collaborates with scholars based in France, United Kingdom and Morocco. Claire Guyomard's co-authors include Sylvie Rumin, Isabelle Cannie, Christiane Guguen‐Guillouzo, Stephan Urban, Jacques Le Seyec, Christian Trépo, Josette Lucas, Philippe Gripon, Denise Glaise and Christophe Chesné and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Hepatology and Toxicology and Applied Pharmacology.

In The Last Decade

Claire Guyomard

20 papers receiving 1.6k citations

Hit Papers

Infection of a human hepatoma cell line by hepatitis B virus 2002 2026 2010 2018 2002 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Guyomard France 14 836 557 420 404 372 20 1.7k
Y Mizoguchi Japan 18 282 0.3× 347 0.6× 194 0.5× 402 1.0× 284 0.8× 161 1.3k
Yannick Laperche France 26 295 0.4× 330 0.6× 285 0.7× 680 1.7× 62 0.2× 51 1.6k
Grushenka H.I. Wolfgang United States 18 565 0.7× 759 1.4× 120 0.3× 219 0.5× 100 0.3× 37 1.4k
Marina H. de Jager Netherlands 17 186 0.2× 120 0.2× 168 0.4× 277 0.7× 303 0.8× 26 1.2k
Richard H. Hinton United Kingdom 26 193 0.2× 193 0.3× 301 0.7× 729 1.8× 326 0.9× 88 1.9k
Ran Fei China 20 284 0.3× 314 0.6× 117 0.3× 429 1.1× 93 0.3× 85 1.4k
Elaine Studer United States 27 280 0.3× 628 1.1× 679 1.6× 884 2.2× 287 0.8× 40 2.4k
Christoph Reichel Germany 20 209 0.3× 300 0.5× 370 0.9× 603 1.5× 126 0.3× 57 2.0k
Yoon Seok Roh South Korea 21 434 0.5× 918 1.6× 157 0.4× 648 1.6× 108 0.3× 48 1.8k

Countries citing papers authored by Claire Guyomard

Since Specialization
Citations

This map shows the geographic impact of Claire Guyomard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Guyomard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Guyomard more than expected).

Fields of papers citing papers by Claire Guyomard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Guyomard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Guyomard. The network helps show where Claire Guyomard may publish in the future.

Co-authorship network of co-authors of Claire Guyomard

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Guyomard. A scholar is included among the top collaborators of Claire Guyomard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Guyomard. Claire Guyomard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meneses‐Lorente, Georgina, Claire Guyomard, Christophe Chesné, et al.. (2006). Utility of Long-Term Cultured Human Hepatocytes as an in Vitro Model for Cytochrome P450 Induction. Drug Metabolism and Disposition. 35(2). 215–220. 16 indexed citations
2.
Vian, Laurence, et al.. (2002). The Liverbeads® as a tool for the comet assay. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 519(1-2). 163–170. 13 indexed citations
3.
Gripon, Philippe, Sylvie Rumin, Stephan Urban, et al.. (2002). Infection of a human hepatoma cell line by hepatitis B virus. Proceedings of the National Academy of Sciences. 99(24). 15655–15660. 996 indexed citations breakdown →
4.
Hoogenboom, L.A.P., G.E. Neal, Ankur Verma, et al.. (2001). Genotoxicity testing of extracts from aflatoxin-contaminated peanut meal, following chemical decontamination. Food Additives & Contaminants. 18(4). 329–341. 1 indexed citations
5.
Hoogenboom, L.A.P., G.E. Neal, Ankur Verma, et al.. (2001). Genotoxicity testing of extracts from aflatoxin-contaminated peanut meal, following chemical decontamination. Food Additives & Contaminants. 18(4). 329–341. 5 indexed citations
6.
Guyomard, Claire, et al.. (2000). Viability and drug metabolism capacity of alginate-entrapped hepatocytes after cryopreservation. Cell Biology and Toxicology. 16(2). 105–116. 42 indexed citations
7.
Guillouzo, André, et al.. (1999). Survival and function of isolated hepatocytes after cryopreservation. Chemico-Biological Interactions. 121(1). 7–16. 63 indexed citations
8.
Chesné, Christophe, et al.. (1998). Metabolism of Meloxicam in human liver involves cytochromes P4502C9 and 3A4. Xenobiotica. 28(1). 1–13. 105 indexed citations
9.
Edgar, Alan D., Céline Tomkiewicz, Philippe Costet, et al.. (1998). Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway. Toxicology Letters. 98(1-2). 13–23. 58 indexed citations
10.
Fautrel, Alain, et al.. (1997). Long-Term Maintenance of Drug-Metabolizing Enzyme Activities in Rat Hepatocytes after Cryopreservation. Toxicology and Applied Pharmacology. 147(1). 110–114. 31 indexed citations
11.
Guyomard, Claire, et al.. (1996). Influence of Alginate Gel Entrapment and Cryopreservation on Survival and Xenobiotic Metabolism Capacity of Rat Hepatocytes. Toxicology and Applied Pharmacology. 141(2). 349–356. 83 indexed citations
12.
Guyomard, Claire, et al.. (1994). Evaluation of PREDISAFE, a cell kit for predicting eye irritancy of cosmetic raw materials and formulations. Cell Biology and Toxicology. 10(5-6). 375–379. 6 indexed citations
13.
Chesné, Christophe, Claire Guyomard, Alain Fautrel, et al.. (1993). Viability and function in primary culture of adult hepatocytes from various animal species and human beings after cryopreservation. Hepatology. 18(2). 406–414. 120 indexed citations
14.
15.
Poullain, Marie‐Gwenaelle, Alain Fautrel, Claire Guyomard, et al.. (1992). Viability and primary culture of rat hepatocytes after hypothermic preservation: The superiority of the leibovitz medium over the university of wisconsin solution for cold storage. Hepatology. 15(1). 97–106. 41 indexed citations
16.
Frémond, B., et al.. (1992). [Extracorporeal bio-artificial liver using isolated hepatocytes. An experimental study in the rat].. PubMed. 118(10). 672–7. 1 indexed citations
17.
Chesné, Christophe, et al.. (1991). Use of cryopreserved animal and human hepatocytes for cytotoxicity studies. Toxicology in Vitro. 5(5-6). 479–482. 14 indexed citations
18.
Loréal, Olivier, et al.. (1991). FK 506 is less cytotoxic than cyclosporine to human and rat hepatocytes in vitro.. PubMed. 23(6). 2825–8. 7 indexed citations
19.
Guyomard, Claire, Christophe Chesné, Bernard Meunier, et al.. (1990). Primary culture of adult rat hepatocytes after 48-hour preservation of the liver with cold UW solution. Hepatology. 12(6). 1329–1336. 40 indexed citations
20.
Guyomard, Claire, et al.. (1989). Evaluation of various parameters in testing drug cytotoxicity in primary hepatocyte cultures.. Europe PMC (PubMed Central). 7. 191–196. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026